Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS)

by Christopher Abraham, MD, Adam Garsa, MD, Shahed N. Badiyan, MD, Robert Drzymala, PhD, Deshan Yang, PhD, Todd DeWees, PhD, Christina Tsien, MD, Joshua L. Dowling, MD, Keith M. Rich, MD, Michael R. Chicoine, MD, Albert H. Kim, MD, PhD, Eric C. Leuthardt, MD, Cliff Robinson, MD
Published 2018-04-01